FI920845A0 - Farmaceutiska kompositioner innehaollande interleukin-2. - Google Patents

Farmaceutiska kompositioner innehaollande interleukin-2.

Info

Publication number: FI920845A0
Authority: FI; Finland
Prior art keywords: interleukin; pharmaceutical composition; composition innehaollande; innehaollande; pharmaceutical
Prior art date: 1991-02-27

Application number

FI920845A

Other languages

English (en)

Other versions

FI920845A (fi

Inventor

Michal Schwartz

Shoshana Eitan

Original Assignee

Yeda Res & Dev

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-02-27

Filing date

1992-02-26

Publication date

1992-02-26

1992-02-26 Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev

1992-02-26 Publication of FI920845A0 publication Critical patent/FI920845A0/fi

1992-08-28 Publication of FI920845A publication Critical patent/FI920845A/fi

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/104—Aminoacyltransferases (2.3.2)
- C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/55—IL-2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/249—Interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Zoology (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Toxicology (AREA)
Immunology (AREA)
Biomedical Technology (AREA)
Gastroenterology & Hepatology (AREA)
Wood Science & Technology (AREA)
Microbiology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Hospice & Palliative Care (AREA)
Vascular Medicine (AREA)
Heart & Thoracic Surgery (AREA)
General Engineering & Computer Science (AREA)
Ophthalmology & Optometry (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Biotechnology (AREA)
Psychiatry (AREA)
Mycology (AREA)
Epidemiology (AREA)

FI920845A 1991-02-27 1992-02-26 Farmaceutiska kompositioner innehaollande interleukin-2 FI920845A (fi)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IL97365A IL97365A0 (en)	1991-02-27	1991-02-27	Pharmaceutical compositions comprising a lymphokine

Publications (2)

Publication Number	Publication Date
FI920845A0 true FI920845A0 (fi)	1992-02-26
FI920845A FI920845A (fi)	1992-08-28

Family

ID=11062144

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI920845A FI920845A (fi)	1991-02-27	1992-02-26	Farmaceutiska kompositioner innehaollande interleukin-2

Country Status (13)

Country	Link
EP (1)	EP0501445A1 (fi)
JP (1)	JPH05238941A (fi)
KR (1)	KR920016106A (fi)
AU (1)	AU647883B2 (fi)
CA (1)	CA2061918A1 (fi)
FI (1)	FI920845A (fi)
HU (2)	HUT66231A (fi)
IE (1)	IE920594A1 (fi)
IL (1)	IL97365A0 (fi)
MY (1)	MY131097A (fi)
NZ (1)	NZ241719A (fi)
TW (1)	TW208657B (fi)
ZA (1)	ZA921416B (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2119873A1 (en) *	1992-07-30	1994-02-17	Michal Schwartz	Enzymatically-produced dimeric il-2 and a nerve-derived transglutaminase enyzme for its preparation
US6267955B1 (en)	1995-09-15	2001-07-31	Yeda Research And Development Co. Ltd.	Mononuclear phagocytes and their use to promote axonal regeneration
US5800812A (en) *	1995-09-15	1998-09-01	Yeda Research And Development Co. Ltd.	Methods of use of mononuclear phagocytes to promote axonal regeneration
CN1181885C (zh)	1996-03-22	2004-12-29	通用医疗公司	中枢神经系统局部缺血或损伤后多肽生长因子的给药

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4832686A (en) *	1986-06-24	1989-05-23	Anderson Mark E	Method for administering interleukin-2
IL91459A0 (en) *	1989-08-28	1990-04-29	Yeda Res & Dev	Oligodendrocyte inhibitory factor

1991
- 1991-02-27 IL IL97365A patent/IL97365A0/xx unknown
1992
- 1992-02-25 IE IE059492A patent/IE920594A1/en not_active Application Discontinuation
- 1992-02-25 NZ NZ241719A patent/NZ241719A/en unknown
- 1992-02-26 HU HU9303167A patent/HUT66231A/hu unknown
- 1992-02-26 CA CA002061918A patent/CA2061918A1/en not_active Abandoned
- 1992-02-26 HU HU9200644A patent/HUT60437A/hu unknown
- 1992-02-26 FI FI920845A patent/FI920845A/fi not_active Application Discontinuation
- 1992-02-26 EP EP92103260A patent/EP0501445A1/en not_active Withdrawn
- 1992-02-26 AU AU11267/92A patent/AU647883B2/en not_active Ceased
- 1992-02-26 ZA ZA921416A patent/ZA921416B/xx unknown
- 1992-02-27 MY MYPI92000322A patent/MY131097A/en unknown
- 1992-02-27 JP JP4090398A patent/JPH05238941A/ja active Pending
- 1992-02-27 KR KR1019920003089A patent/KR920016106A/ko not_active Application Discontinuation
- 1992-04-13 TW TW081102862A patent/TW208657B/zh active

Also Published As

Publication number	Publication date
ZA921416B (en)	1993-01-27
AU647883B2 (en)	1994-03-31
AU1126792A (en)	1992-09-03
MY131097A (en)	2007-07-31
KR920016106A (ko)	1992-09-24
HU9200644D0 (en)	1992-05-28
FI920845A (fi)	1992-08-28
TW208657B (fi)	1993-07-01
NZ241719A (en)	1994-12-22
EP0501445A1 (en)	1992-09-02
CA2061918A1 (en)	1992-08-28
IE920594A1 (en)	1992-09-09
HUT60437A (en)	1992-09-28
HUT66231A (en)	1994-10-28
IL97365A0 (en)	1992-05-25
HU9303167D0 (en)	1994-01-28
JPH05238941A (ja)	1993-09-17

Publication	Publication Date	Title
FI921060A0 (fi)	1992-03-11	Farmaceutiska aerosolformuleringar.
FI922958A0 (fi)	1992-06-25	Farmaceutisk sammansaettning.
FI922252A0 (fi)	1992-05-18	Farmaceutisk sammansaettning.
FI922316A0 (fi)	1992-05-21	Farmaceutisk sammansaettning.
FI901102A0 (fi)	1990-03-05	Farmaceutiska kompositioner.
FI922364A0 (fi)	1992-05-22	Farmaceutiska kompositioner.
FI923581A0 (fi)	1992-08-11	Farmaceutisk kombinationsformation.
FI915826A0 (fi)	1991-12-11	Farmaceutiska aemnen.
DE69101931D1 (de)	1994-06-16	Pharmazeutische Zusammensetzung.
DE69115263D1 (de)	1996-01-18	Pharmazeutische zusammensetzungen.
IT8920486A0 (it)	1989-05-12	Composizioni farmaceutiche.
IT8820386A0 (it)	1988-04-29	Composizioni farmaceutiche orosolubili contenti acetilcisteina.
FI893643A0 (fi)	1989-08-01	Farmaceutiska kompositioner.
MX9200622A (es)	1992-11-01	Composicion farmaceutica
UA26064A1 (uk)	1999-04-30	Фармацевтичhа композиція
FR2674755B1 (fr)	1995-02-03	Nouvelles compositions medicamenteuses immunostimulatrices.
FI923371A (fi)	1992-07-24	En farmaceutisk formulation.
FI920845A0 (fi)	1992-02-26	Farmaceutiska kompositioner innehaollande interleukin-2.
FI921786A0 (fi)	1992-04-22	Farmaceutisk foerening.
DE68907609D1 (de)	1993-08-19	Arzneimittelzusammensetzung.
FI921785A0 (fi)	1992-04-22	Farmaceutisk foerening.
DE69206398D1 (de)	1996-01-11	Reichstoffzusammensetzungen.
FI904932A (fi)	1992-01-11	Optiskt aktiva tiazetokinolin-3 -karboxylsyraderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska kompositioner.
FI922185A0 (fi)	1992-05-13	Faergframkallande komposition.
MX9201791A (es)	1992-10-01	Medicamentos.

Legal Events

Date	Code	Title	Description
1996-09-10	FD	Application lapsed